Associations of IGF1 and its binding proteins with abdominal aortic aneurysm and aortic diameter in older men

European Journal of Endocrinology

Volumn 166, Issue 2, 2012, Pages 191-197

  Yeap, Bu B ^a,b   Chubb, S A Paul ^a,b   McCaul, Kieran A ^c   Flicker, Leon ^a,c   Ho, Ken K Y ^d   Golledge, Jonathan ^e   Hankey, Graeme J ^a   Norman, Paul E ^f  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d PRINCESS ALEXANDRA HOSPITAL   (Australia)

^e JAMES COOK UNIVERSITY   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ABDOMINAL AORTA ANEURYSM; ABDOMINAL RADIOGRAPHY; AGE; AGED; ARTICLE; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ECHOGRAPHY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; ORGAN SIZE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK FACTOR; SENSITIVITY ANALYSIS;

AGED; AGED, 80 AND OVER; AGING; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; MULTIVARIATE ANALYSIS; ORGAN SIZE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84856085479     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0725     Document Type: Article

References (37)

1. Sherlock M & Toogood AA. Aging and the growth hormone/insulin like growth factor-I axis. Pituitary 2007 10 189-203. (doi:10.1007/s11102-007-0039-5)
2. Ohlsson C, Mohan S, Sjogren K, Tivesten A, Isgaard J, Isaksson O, Jansson J-O & Svensson J. The role of liver-derived insulin-like growth factor-I. Endocrine Reviews 2009 30 494-535. (doi:10.1210/er.2009-0010)
3. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Hormone and IGF Research 2003 13 113-170. (doi:10.1016/S1096-6374(03)00038-8)
4. Kotronen A, Lewitt M, Hall K, Brismar K & Yki-Jarvinen H. Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 2008 93 4867-4872. (doi:10.1210/jc.2008-1245)
5. Norman P, Le M, Pearce C & Jamrozik K. Infrarenal aortic diameter predicts all-cause mortality. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 1278-1282. (doi:10.1161/01.ATV.0000131261.12051.7f)
6. Freiberg MS, Arnold AM, Newman AB, Edwards MS, Kraemer KL & Kuller LH. Abdominal aortic aneurysms, increasing infrarenal aortic diameter, and risk of total mortality and incident cardiovascular disease events. Circulation 2008 117 1010-1017. (doi:10.1161/CIRCULATIONAHA.107.720219)
7. Johnsen SH, Forsdahl S, Singh K & Jacobsen BK. Atherosclerosis in abdominal aortic aneurysms: a causal event of a process running in parallel? The Tromso Study. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 1263-1268. (doi:10.1161/ATVBAHA.110.203588)
8. Grant MB, Wargovich TJ, Ellis EA, Tarnuzzer R, Caballero S, Estes K, Rossing M, Spoerri PE & Pepine C. Expression of IGF-I, IGF-I receptor and IGF binding proteins -1, -2, -3, -4 and -5 in human atherectomy specimens. Regulatory Peptides 1996 67 137-144. (doi:10.1016/S0167-0115(96)00124-3)
9. Juul A, Scheike T, Davidsen M, Gyllenborg J & Jorgensen T. Low serum insulin-like growth factor 1 is associated with increased risk of ischemic heart disease. A population-based case-control study. Circulation 2002 106 939-944. (doi:10.1161/01.CIR.0000027563.44593.CC)
10. Johnsen SP, Hundborg HH, Sorensen HT, Orskov H, Tjonneland A, Overvad K & Jorgensen JO. Insulin-like growth factor (IGF) I, -II and IGF binding protein-3 and risk of ischemic stroke. Journal of Clinical Endocrinology and Metabolism 2005 90 5937-5941. (doi:10.1210/jc.2004-2088)
11. Panek B, Gacko M & Palka J. Metalloproteinases, insulin-like growth factor-I and its binding proteins in aortic aneurysm. International Journal of Experimental Pathology 2004 85 159-164. (doi:10.1111/j.0959-9673.2004.00386.x)
12. Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Malarstig A, Brismar K, Hamsten A, Fisher RM & Hellenius M-L. IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome. Clinical Science 2009 116 507-512. (doi:10.1042/CS20080382)
13. Norman PE, Flicker L, Almeida OP, Hankey GJ, Hyde Z & Jamrozik K. Cohort profile: the Health In Men Study (HIMS). International Journal of Epidemiology 2009 38 48-52. (doi:10. 1093/ije/dyn041)
14. Holman CD, Bass AJ, Rouse IL & Hobbs MS. Population-based linkage of health records in Western Australia: development of a health services research linked database. Australian and New Zealand Journal of Public Health 1999 23 453-459. (doi:10.1111/j.1467-842X.1999.tb01297.x)
15. Norman P, Spencer CA, Lawrence-Brown MM & Jamrozik K. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation 2004 110 862-866. (doi:10.1161/01.CIR.0000138746.14425.00)
16. Wilmink A, Hubbard C, Day N & Quick C. The incidence of small abdominal aortic aneurysms and the change in normal infrarenal aortic diameter: implications for screening. European Journal of Vascular and Endovascular Surgery 2001 21 165-170. (doi:10.1053/ejvs.2000.1285)
17. Yeap BB, Chubb SAP, Ho KKY, Setoh JWS, McCaul KA, Norman PE, Jamrozik K & Flicker L. Insulin-like growth factor-I and its binding proteins 3 and 1 are differentially associated with metabolic syndrome in older men. European Journal of Endocrinology 2010 162 249-257. (doi:10.1530/EJE-09-0852)
18. Vasan RS, Sullivan LM, D'Agostino RB, Roubenoff R, Harris T, Sawyer DB, Levy D &Wilson PW. Serum insulin-like growth factor 1 and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Annals of Internal Medicine 2003 139 642-648.
19. Laughlin GA, Barrett-Connor E, Criqui MH & Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular mortality in older adults: the Rancho Bernardo study. Journal of Clinical Endocrinology and Metabolism 2004 89 114-120. (doi:10.1210/jc.2003-030967)
20. Brugts MP, van den Beld AW, Hofland LJ, van der Wansem K, van Koetsveld PM, Frystyk J, Lamberts SWJ & Janssen JAMJL. Low circulating insulin-like growth factor I bioactivity in elderly men is associated with increased mortality. Journal of Clinical Endocrinology and Metabolism 2008 93 2515-2522. (doi:10.1210/jc.2007-1633)
21. Van Bunderen CC, van Nieuwpoort IC, van Schoor NM, Deeg DJH, Lips P & Drent ML. The association of serum insulin-like growth factor-I with mortality, cardiovascular disease, and cancer in the elderly: a population-based study. Journal of Clinical Endocrinology and Metabolism 2010 95 4616-4624. (doi:10.1210/jc.2010-0940)
22. Golledge J, Muller J, Daugherty A & Norman PE. Abdominal aortic aneurysm: pathogenesis and implications for management. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 2605-2613. (doi:10.1161/01.ATV. 0000245819.32762.cb)
23. Lindholt JS, Martin-Ventura JL, Urbonavicius S, Ramos-Mozo P, Flyvbjerg A, Egido J, Henneberg EW & Frystyk J. Insulin-like growth factor I - a novel biomarker of abdominal aortic aneurysms. European Journal of Vascular and Endovascular Surgery 2011 42 560-562. (doi:10.1016/j.ejvs.2011.07.013)
24. Yamawaki-Ogata A, Hashizume R, Satake M, Kaneko H, Mizutani S, Moritan T, Ueda Y & Narita Y. A doxycycline loaded, controlled-release, biodegradable fiber for the treatment of aortic aneurysms. Biomaterials 2010 31 9554-9564. (doi:10.1016/j.biomaterials.2010.08.069)
25. Etheredge L, Kane BP, Valkov N, Adams S, Birk DE & Hassell JR. Enhanced cell accumulation and collagen processing by keratocytes cultured under agarose and in media containing IGF-I, TGFb or PDGF. Matrix Biology 2010 29 519-524. (doi:10.1016/j.matbio.2010.05.003)
26. Jeschke MG, Schubert T, Krickhahn M, Polykandriotis E, Klein D, Perez-Polo JR, Przkora R & Herndon DN. Interaction of exogenous liposomal insulin-like growth factor-I cDNA gene transfer with growth factors on collagen expression in acute wounds. Wound Repair and Regeneration 2005 13 269-277. (doi:10.1111/j.1067-1927.2005.130309.x)
27. Delafontaine P, Song Y-H & Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 435-444. (doi:10.1161/01.ATV.0000105902.89459.09)
28. Conti E, Musumeci MB, De Giusti M, Dito E, Mastromarino V, Autore C & Volpe M. IGF-I and atherothrombosis: relevance to pathophysiology and therapy. Clinical Science 2011 120 377-402. (doi:10.1042/CS20100400)
29. Allaire E, Muscatelli-Groux B, Guinault A-M, Pages C, Goussard A, Mandet C, Bruneval P, Melliere D & Becquemin J-P. Vascular smooth muscle cell endovascular therapy stabilizes already developed aneurysms in a model of aortic injury elicited by inflammation and proteolysis. Annals of Surgery 2004 239 417-427. (doi:10.1097/01.sla.0000114131.79899.82)
30. Rietveld I, Janssen JA, van Rossum EF, Houwing-Duistermaat JJ, Rivadeneira F, Hofman A, Pols HA, van Duijn CM & Lamberts SW. A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height. Clinical Endocrinology 2004 61 195-203. (doi:10.1111/j.1365-2265.2004.02078.x)
31. Leinonen ES, Salonen JT, Salonen RM, Koistinen RA, Leinonen PJ, Sarna SS & Taskinen M-R. Reduced IGFBP-1 is associated with thickening of the carotid wall in type 2 diabetes. Diabetes Care 2002 25 1807-1812. (doi:10.2337/diacare. 25.10.1807)
32. Harrela M, Qiao Q, Koistinen R, Tuomilehto J, Nissinen A, Seppala M & Leinonen P. High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men. Hormone and Metabolic Research 2002 34 144-149. (doi:10.1055/s-2002-23198)
33. Hu D, Pawlikowska L, Kanaya A, Hsueh W-C, Colbert L, Newman AB, Satterfield S, Rosen C, Cummings SR, Harris TB & Ziv E. Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: the health, aging, and body composition study. Journal of the American Geriatrics Society 2009 57 1213-1218. (doi:10.1111/j.1532-5415.2009.02318.x)
34. Yeap BB, Chubb SAP, McCaul KA, Ho KKY, Hankey GJ, Norman PE & Flicker L. Associations of insulin-like growth factor-I and its binding proteins 1 and 3 with all-cause and cardiovascular mortality in older men. The Health In Men Study. European Journal of Endocrinology 2011 164 715-723. (doi:10.1530/EJE-11- 0059)
35. Wheatcroft SB & Kearney MT. IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis. Trends in Endocrinology and Metabolism 2009 20 153-162. (doi:10.1016/j.tem.2009.01. 002)
36. Yeap BB, Hyde Z, Norman PE, Chubb SAP & Golledge J. Associations of total testosterone, sex hormone-binding globulin, calculated free testosterone, and luteinising hormone with prevalence of abdominal aortic aneurysm in older men. Journal of Clinical Endocrinology and Metabolism 2010 95 1123-1130. (doi:10.1210/jc.2009-1696)
37. Forsdahl SH, Singh K, Solberg S & Jacobsen BK. Risk factors for abdominal aortic aneurysms. A 7-year prospective study: the Tromso Study, 1994-2001. Circulation 2009 119 2201-2208. (doi:10.1161/CIRCULATIONAHA.108. 817619)